Method for treating ischemia

• US 7,001,336 B2
• Filed: 04/01/2004
• Issued: 02/21/2006
• Est. Priority Date: 01/30/2001
• Status: Expired due to Fees

• Current Assignee: Advanced Cardiovascular Systems Incorporated
• Original Assignee: Advanced Cardiovascular Systems Incorporated
• Inventors: Mandrusov, Evgenia, Sherman, Marshall, Steward, Jeffrey
• Primary Examiner(s): DAHBOUR, HENRY
• Application Number:
  US10/817,358
• Publication Number:
  US 20040193051A1
• Time in Patent Office: 691 Days
• Field of Search: 600/439, 600/549, 600/462, 600/509, 600/515, 600/523, 600/437, 600/508, 606/200, 606/27, 606/28, 606/29, 606/31, 601/2, 601/3, 128/898, 607/122, 604/22
• US Class Current: 600/439
• CPC Class Codes: A61B 2017/00247 Making holes in the wall of the heart, e.g. laser Myocardial revascularization
• CPC Class Codes: A61B 2018/00392 Transmyocardial revascularisation
• CPC Class Codes: A61N 7/022 intracavitary

Abstract

A method and apparatus for improving blood flow to an ischemic region (e.g., myocardial ischemia) a patient is provided. An ultrasonic transducer is positioned proximate to the ischemic region. Ultrasonic energy is applied at a frequency at or above 1 MHz to create one or more thermal lesions in the ischemic region of the myocardium. The thermal lesions can have a gradient of sizes. The ultrasound transducer can have a curved shape so that ultrasound energy emitted by the transducer converges to a site within the myocardium, to create a thermal lesion without injuring the epicardium or endocardium.

Claims

1. A method of treating an ischemic region of a patient, comprising creating a concentration gradient of an angiogenesis stimulating substance in the ischemic region and/or in tissue of a region adjacent the ischemic region, wherein the concentration gradient is formed by creating a first lesion in the ischemic region or in the tissue of the region adjacent the ischemic region and creating a second lesion in the ischemic region or in the tissue of the region adjacent the ischemic region, and wherein the lesions have different sizes.

2. The method of claim 1, wherein the region adjacent the ischemic region is non-ischemic.

4. The method of claim 1, wherein the concentration of the angiogenesis stimulating substance is higher in the ischemic region than in the tissue of the region adjacent the ischemic region.

5. The method of claim 1, wherein the region adjacent the ischemic region is less ischemic than the ischemic region.

3. A method of treating an ischemic region of a patient, comprising creating a concentration gradient of an angiogenesis stimulating substance in the ischemic region and/or in tissue of a region adjacent the ischemic region, wherein the concentration of the angiogenesis stimulating substance is highest at about the center of the ischemic region.

6. The method of claim 3, wherein the region adjacent the ischemic region is non-ischemic.

15. The method of claim 3, wherein the region adjacent the ischemic region is less ischemic than the ischemic region.

7. A method of treating an ischemic region of a patient, comprising creating a concentration gradient of an angiogenesis stimulating substance in the ischemic region and/or in tissue of a region adjacent the ischemic region, wherein the concentration of the angiogenesis stimulating substance is lower in the ischemic region than in the tissue of the region adjacent the ischemic region.

16. The method of claim 7, wherein the region adjacent the ischemic region is less ischemic than the ischemic region or wherein the region adjacent the ischemic region is non-ischemic.

8. A method of treating a region of ischemic tissue in a patient, comprising triggering the release of an angiogenesis stimulating substances to create a concentration variance of the angiogenesis stimulating substances in the region of ischemic tissue and/or in tissue of a region adjacent the region of ischemic tissue, wherein the concentration variance is formed by creating a first lesion in the ischemic region or in the region adjacent the ischemic region and creating a second lesion in the ischemic region or in the region adjacent the ischemic region, and wherein the lesions have different sizes.

9. The method of claim 8, wherein the angiogenesis stimulating substance is released by the region of ischemic tissue.

17. The method of claim 8, wherein the region adjacent the ischemic region is less ischemic than the ischemic region or wherein the region adjacent the ischemic region is non-ischemic.

10. A method of treating a region of ischemic tissue in a patient, comprising triggering the release of an angiogenesis stimulating substance to create a concentration variance of the angiogenesis stimulating substance in the region of ischemic tissue and/or in tissue of a region adjacent the region of ischemic tissue, wherein the angiogenesis stimulating substance is released by the tissue of the region adjacent to the region of ischemic tissue.

18. The method of claim 10, wherein the region adjacent the ischemic region is less ischemic than the ischemic region or wherein the region adjacent the ischemic region is non-ischemic.

11. A method of treating ischemic myocardial tissue of a patient, comprising:

inserting into the patient a catheter having a tissue stimulating device;

positioning the tissue stimulating device on or near the ischemic myocardial tissue; and

stimulating the ischemic myocardial tissue and/or myocardial tissue near the ischemic myocardial tissue without piercing or cutting the myocardial tissue to trigger the release of an angiogenic factor.

12. The method of claim 11, wherein the stimulation creates a concentration gradient of the angiogenic factor.

13. A method of claim 11, further comprising:

repositioning the tissue stimulating device; and

stimulating the ischemic myocardial tissue and/or myocardial tissue near the ischemic myocardial tissue without piercing or cutting the myocardial tissue to trigger the additional release of the angiogenic factor.

14. The method of claim 13, wherein the stimulation creates a concentration gradient of the angiogenic factor.

19. The method of claim 11, wherein the tissue stimulating device produces a thermal lesion.

20. The method of claim 11, wherein the tissue stimulating device includes a generator of ultrasound.

21. The method of claim 11, wherein the tissue stimulating device generates heat and the method additionally comprises controlling the temperature of the tissue stimulating device.

22. The method of claim 11, wherein the tissue stimulating device can produce multiple thermal lesions simultaneously.

23. The method of claim 11, wherein the tissue stimulating device includes an array of transducers.

24. The method of claim 23, wherein the array of transducers can be selectively activated.

25. The method of claim 23, wherein each transducer within the array can be individually controlled.

26. The method of claim 11, wherein the tissue stimulating device includes a transducer having a curved surface.

27. A method of treating a patient, comprising:

inserting into the patient a catheter assembly having a tissue stimulating device;

positioning the tissue stimulating device over or near a ischemic region;

using the tissue stimulating device to cause the release of an angiogenic substance without piercing or cutting the tissue over which the tissue stimulating device is positioned.

28. The method of claim 27, additionally comprising readjusting the positioning of the tissue stimulating device and causing the release of the angiogenic substance without piercing or cutting the tissue over which the tissue stimulating device is positioned.

29. The method of claim 27, wherein the tissue stimulating device produces a thermal lesion.

30. The method of claim 27, wherein the tissue stimulating device includes a generator of ultrasound.

31. The method of claim 27, wherein the tissue stimulating device generates heat and the method additionally comprises controlling the temperature of the tissue stimulating device.

32. The method of claim 27, wherein the tissue stimulating device can produce multiple thermal lesions simultaneously.

33. The method of claim 27, wherein the tissue stimulating device includes an array of transducers.

34. The method of claim 33, wherein the array of transducers can be selectively activated.

35. The method of claim 33, wherein each transducer within the array can be individually controlled.

36. The method of claim 27, wherein the tissue stimulating device includes a transducer having a curved surface.